Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caterina Labanca

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
European Journal of Haematology|April 20, 2026
From Time-Limited Therapy to Treatment-Free Observation: The Evolving Role of MRD in CLL ManagementEnrica Antonia Martino, Santino Caserta, Ernesto Vigna, et al.
Annals of Hematology|May 4, 2026
High-dose ruxolitinib (25 mg twice daily) in myelofibrosis: feasibility, safety, and long-term treatment exposure in a real-world cohortFrancesco Mendicino, Giulio Caridà, Antonella Bruzzese, et al.
European Journal of Haematology|July 9, 2026
Bridging Randomized Trial Efficacy and Real-World Effectiveness in Multiple Myeloma: Integrating Clinical Trials and Real-World Evidence for Individualized CareEnrica Antonia Martino, Ernesto Vigna, Antonella Bruzzese, et al.
Biomedicines|May 28, 2022
A Prognostic and Carboplatin Response Predictive Model in Ovarian Cancer: A Mono-Institutional Retrospective Study Based on Clinics and PharmacogenomicsNicoletta Staropoli, Mariamena Arbitrio, Angela Salvino, et al.
European Journal of Haematology|April 15, 2026
First-Line Treatment of IGHV-Unmutated Chronic Lymphocytic Leukemia: A Network Meta-Analysis of Targeted and Chemoimmunotherapy RegimensSantino Caserta, Enrica Antonia Martino, Danilo Lofaro, et al.
European Journal of Haematology|February 19, 2025
Relapsed/Refractory Follicular Lymphoma: Current Advances and Emerging PerspectivesGiulio Caridà, Enrica Antonia Martino, Antonella Bruzzese, et al.
European Journal of Haematology|April 27, 2026
Minimal Residual Disease as a Biological Trait: Rethinking Disease Persistence in Hematologic MalignanciesSantino Caserta, Enrica Antonia Martino, Ernesto Vigna, et al.
Hematology Reports|July 25, 2023
Safe and Effective Administration of Caplacizumab in COVID-19-Associated Thrombotic Thrombocytopenic PurpuraAntonella Bruzzese, Ernesto Vigna, Dario Terzi, et al.
Critical Reviews in Oncology/Hematology|December 8, 2023
The impact of PARP inhibitors in the whole scenario of ovarian cancer management: A systematic review and network meta-analysisNicoletta Staropoli, Domenico Ciliberto, Francesco Luciano, et al.
Nutrients|May 13, 2026
The Gut Microbiota in Hematologic Malignancies: Mechanisms, Clinical Associations, and Translational OpportunitiesSantino Caserta, Enrica Antonia Martino, Mamdouh Skafi, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
European Journal of Haematology|April 20, 2026
From Time-Limited Therapy to Treatment-Free Observation: The Evolving Role of MRD in CLL ManagementEnrica Antonia Martino, Santino Caserta, Ernesto Vigna, et al.
Annals of Hematology|May 4, 2026
High-dose ruxolitinib (25 mg twice daily) in myelofibrosis: feasibility, safety, and long-term treatment exposure in a real-world cohortFrancesco Mendicino, Giulio Caridà, Antonella Bruzzese, et al.
European Journal of Haematology|July 9, 2026
Bridging Randomized Trial Efficacy and Real-World Effectiveness in Multiple Myeloma: Integrating Clinical Trials and Real-World Evidence for Individualized CareEnrica Antonia Martino, Ernesto Vigna, Antonella Bruzzese, et al.
Biomedicines|May 28, 2022
A Prognostic and Carboplatin Response Predictive Model in Ovarian Cancer: A Mono-Institutional Retrospective Study Based on Clinics and PharmacogenomicsNicoletta Staropoli, Mariamena Arbitrio, Angela Salvino, et al.
European Journal of Haematology|April 15, 2026
First-Line Treatment of IGHV-Unmutated Chronic Lymphocytic Leukemia: A Network Meta-Analysis of Targeted and Chemoimmunotherapy RegimensSantino Caserta, Enrica Antonia Martino, Danilo Lofaro, et al.
European Journal of Haematology|February 19, 2025
Relapsed/Refractory Follicular Lymphoma: Current Advances and Emerging PerspectivesGiulio Caridà, Enrica Antonia Martino, Antonella Bruzzese, et al.
European Journal of Haematology|April 27, 2026
Minimal Residual Disease as a Biological Trait: Rethinking Disease Persistence in Hematologic MalignanciesSantino Caserta, Enrica Antonia Martino, Ernesto Vigna, et al.
Hematology Reports|July 25, 2023
Safe and Effective Administration of Caplacizumab in COVID-19-Associated Thrombotic Thrombocytopenic PurpuraAntonella Bruzzese, Ernesto Vigna, Dario Terzi, et al.
Critical Reviews in Oncology/Hematology|December 8, 2023
The impact of PARP inhibitors in the whole scenario of ovarian cancer management: A systematic review and network meta-analysisNicoletta Staropoli, Domenico Ciliberto, Francesco Luciano, et al.
Nutrients|May 13, 2026
The Gut Microbiota in Hematologic Malignancies: Mechanisms, Clinical Associations, and Translational OpportunitiesSantino Caserta, Enrica Antonia Martino, Mamdouh Skafi, et al.
Pageof 6